These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 10622546)
1. Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure. Parissis JT; Venetsanou KF; Mentzikof DG; Ziras NG; Kefalas CG; Karas SM Scand Cardiovasc J; 1999; 33(6):344-50. PubMed ID: 10622546 [TBL] [Abstract][Full Text] [Related]
2. The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia. Adigun AQ; Ajayi AA Eur J Heart Fail; 2001 Jun; 3(3):359-63. PubMed ID: 11378008 [TBL] [Abstract][Full Text] [Related]
3. The clinical relevance of circulating tumor necrosis factor-alpha in acute decompensated chronic heart failure without cachexia. Milani RV; Mehra MR; Endres S; Eigler A; Cooper ES; Lavie CJ; Ventura HO Chest; 1996 Oct; 110(4):992-5. PubMed ID: 8874257 [TBL] [Abstract][Full Text] [Related]
4. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables. Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580 [TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Ferrari R; Bachetti T; Confortini R; Opasich C; Febo O; Corti A; Cassani G; Visioli O Circulation; 1995 Sep; 92(6):1479-86. PubMed ID: 7664430 [TBL] [Abstract][Full Text] [Related]
7. The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy. Liu L; Zhao SP Int J Cardiol; 1999 Apr; 69(1):77-82. PubMed ID: 10362376 [TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-kappaB activity in peripheral blood mononuclear cells in cachectic and non-cachectic patients with chronic heart failure. Siednienko J; Jankowska EA; Banasiak W; Gorczyca WA; Ponikowski P Int J Cardiol; 2007 Nov; 122(2):111-6. PubMed ID: 17270295 [TBL] [Abstract][Full Text] [Related]
9. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [TBL] [Abstract][Full Text] [Related]
10. Expression of proinflammatory cytokines in the failing human heart: comparison of recent-onset and end-stage congestive heart failure. Kubota T; Miyagishima M; Alvarez RJ; Kormos R; Rosenblum WD; Demetris AJ; Semigran MJ; Dec GW; Holubkov R; McTiernan CF; Mann DL; Feldman AM; McNamara DM J Heart Lung Transplant; 2000 Sep; 19(9):819-24. PubMed ID: 11008069 [TBL] [Abstract][Full Text] [Related]
11. Congestive heart failure and ventricular arrhythmias in relation to serum magnesium. Oladapo OO; Falase AO Afr J Med Med Sci; 2000; 29(3-4):265-8. PubMed ID: 11714003 [TBL] [Abstract][Full Text] [Related]
12. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. McMurray J; Abdullah I; Dargie HJ; Shapiro D Br Heart J; 1991 Nov; 66(5):356-8. PubMed ID: 1747295 [TBL] [Abstract][Full Text] [Related]